Omega Healthcare Investors, Inc. (OHI) AI Stock Analysis

Omega Healthcare Investors, Inc. is a real estate investment trust that specializes in long-term investments in the healthcare sector, specifically focusing on skilled nursing and assisted living facilities. Properties in its portfolio are primarily leased under a triple-net lease structure intended to produce stable and predictable cash flows. The company operates across the United States and has expanded internationally into the United Kingdom. Omega partners with a diverse range of healthcare operators to enhance operational diversity and portfolio resilience, providing essential real estate solutions to care providers while seeking long-term value creation.

Revenue increased from $1.06B in FY2021 to $1.20B in FY2025, recording a 5-year revenue CAGR of 6.1%. Annual revenue contracted 17.4% in FY2022 to $878.2M before rebounding with 8.1% growth in FY2023, 10.7% in FY2024, and 14.0% in FY2025. Operating margin was 62.6% in FY2025, while net margin reached 49.3% with net income of $590.1M and EPS of $2.03. For the latest quarter ended June 30, 2026, revenue increased 11.2% year-over-year, and quarterly earnings grew 161.3% compared to the prior-year period.

As of June 30, 2026, Omega Healthcare Investors held $39.0M in cash and short-term investments against $4.02B in total debt, resulting in net debt of $3.98B. Total assets stood at $10.04B and shareholders' equity was $5.39B, yielding a debt-to-equity ratio of 0.75 and a current ratio of 0.91. During FY2025, the company generated $878.6M in operating cash flow and free cash flow. In that fiscal year, capital expenditures were $716.6M, dividends paid totaled $780.4M, and share issuance raised $606.8M.

At $45.64 per share, OHI trades at a trailing P/E of 16.3x and a forward P/E of 10.1x, below the median of its US-listed Real Estate peers of 21.6x and 23.5x, respectively. Its enterprise value-to-EBITDA ratio is 12.6x, compared to the peer median of 14.7x, while its price-to-sales of 11.6x is above the peer median of 3.7x. Over the past year, OHI generated a total return of 19.9%, compared to 16.8% for the S&P 500 (SPY), and delivered a 5-year return of 116.4% versus 83.0% for the index.

OHI offers a forward annual dividend of $2.72 per share, representing a 5.96% dividend yield. The company pays dividends quarterly and has paid dividends for 24 consecutive years, although its 5-year annualized dividend growth is 0.0%. Its payout ratio stands at 110.7%. The most recent ex-dividend date was August 3, 2026.

Wall Street coverage includes 6 Strong Buy, 2 Buy, 10 Hold, and 2 Sell ratings. The mean price target is $51.44, representing a 12.7% premium over the last close of $45.64. For the fiscal year ending December 31, 2026, consensus estimates project EPS of $1.98 on revenue of $1.08B. For the subsequent fiscal year, analysts forecast EPS of $2.02 and revenue of $1.15B. The company beat EPS estimates in 3 of the last 4 quarters, and its next earnings date is November 3, 2026.

This page is an AI-written research summary of Omega Healthcare Investors, Inc. (OHI). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: OHI income statement, OHI balance sheet, OHI key metrics, OHI analyst forecast, OHI chart. See the OHI stock overview for the latest quote and news.